Afrezza Inhaler Device

Afrezza inhaler is a breath-powered device designed to deliver inhaled insulin Afrezza for the management of diabetes mellitus. It is prescribed for adults with type 1 or type 2 diabetes who require rapid-acting insulin to control blood glucose levels following meals. The effectiveness of Afrezza inhaler lies in its rapid absorption via the lungs, which helps reduce post-meal glucose spikes. As an alternative to injections, this device offers a needle-free option for insulin administration. The Afrezza inhaler device does not contain insulin independently. It functions only with Afrezza insulin cartridges containing dry powder human insulin. The inhaler itself is reusable, while the cartridges are single-use and available in different strengths. Afrezza inhaler dosage is determined by the doctor based on meal size, blood glucose readings, and individual insulin requirements. Patients frequently enquire whether Afrezza is safe for teenagers, and its use in younger individuals should be determined strictly by a healthcare professional. As with any insulin therapy, users should be aware of possible Afrezza inhaler side effects, such as cough, throat irritation, or hypoglycaemia. Before starting therapy, patients should receive proper training to ensure correct inhalation technique and safe use. Those considering treatment often enquire about the Afrezza inhaler price, which may vary depending on availability and pharmacy. A healthcare provider should be consulted to confirm suitability and correct usage before starting Afrezza therapy.

The Afrezza Inhaler Device is used to administer rapid-acting inhaled insulin for: Mealtime blood glucose control in adults with type 1 diabetes (used in combination with long-acting basal insulin). Mealtime blood glucose control in adults with type 2 diabetes who require insulin therapy. Reduction of postprandial (after-meal) blood sugar spikes.

When used with Afrezza insulin cartridges, the inhaler delivers insulin directly to the lungs, where it is rapidly absorbed into the bloodstream. This leads to a faster onset of action than many rapid-acting injectable insulins. The insulin begins working within minutes of inhalation, closely mimicking the body’s natural insulin response to meals. This rapid absorption helps improve post-meal glucose control and reduces prolonged insulin exposure, which may lower the risk of delayed hypoglycemia. Consistent use as prescribed supports better overall glycaemic control when combined with diet, exercise, and basal insulin where required.

Common Side Effects: Cough Throat irritation Hypoglycemia Headache Serious Side Effects: Bronchospasm Decline in lung function Severe hypoglycemia Allergic reactions Seek immediate medical attention if you experience breathing difficulty, chest tightness, or severe allergic symptoms.